Chemoinformaics analysis of 3,4-DIMETHOXYPHENANTHRENE-2,7-DIOL
| Molecular Weight | 270.284 | nRot | 2 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 16 |
| Exact Molecular Weight | 270.089 | nRing | 3 |
| Solubility: LogS | -3.661 | nHRing | 0 |
| Solubility: LogP | 3.324 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 3 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 16 |
| nHA | 4 | APOL | 39.2631 |
| nHD | 2 | BPOL | 17.5169 |
| QED | 0.7 |
| Synth | 2.284 |
| Natural Product Likeliness | 1.337 |
| NR-PPAR-gamma | 0.904 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.01 |
| HIA | 0.008 |
| CACO-2 | -4.862 |
| MDCK | 0.0000226 |
| BBB | 0.027 |
| PPB | 0.954011 |
| VDSS | 0.521 |
| FU | 0.0638812 |
| CYP1A2-inh | 0.983 |
| CYP1A2-sub | 0.937 |
| CYP2c19-inh | 0.572 |
| CYP2c19-sub | 0.139 |
| CYP2c9-inh | 0.512 |
| CYP2c9-sub | 0.935 |
| CYP2d6-inh | 0.73 |
| CYP2d6-sub | 0.887 |
| CYP3a4-inh | 0.571 |
| CYP3a4-sub | 0.207 |
| CL | 11.917 |
| T12 | 0.694 |
| hERG | 0.127 |
| Ames | 0.749 |
| ROA | 0.324 |
| SkinSen | 0.95 |
| Carcinogencity | 0.571 |
| EI | 0.969 |
| Respiratory | 0.701 |
| NR-Aromatase | 0.478 |
| Antiviral | Yes |
| Prediction | 0.710222 |